During the last years, the worldwide prevalence of diabetes mellitus type II (DM2) has increased dramatically, impacting the cardiovascular morbidity and mortality. It has been estimated that more than 171 million people suffer this disease (2.8% of the worldwide population) and it's predicted that it will increase to 366 million (6.5 %) in 2030, from which 298 million will be from developing countries. Currently, in Latin America, the DM2 prevalence ranges are between 1.2% and 8%, and it is expected to increase 38% during the next 10 years, with higher levels in the urban zones.